Insider Transactions in Q3 2021 at Nkarta, Inc. (NKTX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2021
|
Paul J Hastings Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,500
-1.87%
|
$221,000
$26.87 P/Share
|
|
Sep 01
2021
|
Ralph Brandenberger Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
4,140
-100.0%
|
$132,480
$32.08 P/Share
|
|
Sep 01
2021
|
Ralph Brandenberger Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,140
+39.36%
|
$12,420
$3.24 P/Share
|
|
Aug 05
2021
|
Kanya Rajangam Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$370,000
$37.28 P/Share
|
|
Aug 05
2021
|
Kanya Rajangam Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$0
$0.41 P/Share
|
|
Aug 02
2021
|
James Trager Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,600
-7.5%
|
$111,600
$31.53 P/Share
|
|
Aug 02
2021
|
James Trager Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+4.48%
|
$6,750
$3.89 P/Share
|
|
Jul 01
2021
|
Nadir Mahmood President |
SELL
Open market or private sale
|
Direct |
6,500
-19.24%
|
$201,500
$31.71 P/Share
|
|
Jul 01
2021
|
Nadir Mahmood President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+9.39%
|
$10,500
$3.89 P/Share
|